- Cardiovascular Involvement
- General
- Topol EJ. COVID-19 Can Affect the Heart. Science. Sep 2020.
- Bearse M, et al. Factors Associated With Myocardial SARS-CoV-2 Infection, Myocarditis, and Cardiac Inflammation in Patients With COVID-19. Mod Pathol. Mar 2021.
- Coromilas EJ, et al. Worldwide Survey of COVID-19 Associated Arrhythmias. Circ Arrhythm Electrophysiol. Feb 2021.
- Rudski L, et al. Multimodality Imaging in Evaluation of Cardiovascular Complications in Patients With COVID-19: JACC Scientific Expert Panel. J Am Coll Cardiol. Sep 2020.
- Puntmann VO, et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. Jul 2020.
- Huang L, et al. Cardiac Involvement in Patients Recovered From COVID-2019 Identified Using Magnetic Resonance Imaging. JACC Cardiovasc Imaging. May 2020.
- Liu PP, et al. The Science Underlying COVID-19: Implications for the Cardiovascular System. Circulation. Apr 2020.
- Hendren NS, et al. Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome. Circulation. Apr 2020.
- Lindner D, et al. Association of Cardiac Infection with SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. JAMA Cardiol. Jul 2020.
- Post-COVID Inflammatory Heart Disease in Professional Athletes: Martinez MW, et al. Prevalence of Inflammatory Heart Disease Among Professional Athletes With Prior COVID-19 Infection Who Received Systematic Return-to-Play Cardiac Screening. JAMA Cardiol. Mar 2021.
- Post-COVID Pericarditis in Athletes: Brito D, et al. High Prevalence of Pericardial Involvement in College Student Athletes Recovering From COVID-19. JACC Cardiovasc Imaging. Nov 2020. (Also see, COVID and The Athletic Heart)
- Hwang CE, et al. Findings from Cardiovascular Evaluation of NCAA Division I Collegiate Student-Athletes after Asymptomatic or Mildly Symptomatic SARS-CoV-2 Infection. Jan 2021. (Not Peer Reviewed)
- Post-COVID Myocarditis/MRI in Athletes: Clark DE, et al. COVID-19 Myocardial Pathology Evaluation in AthleTEs with Cardiac Magnetic Resonance (COMPETE CMR). Circulation. Dec 2020.
- Post-COVID Myocarditis/Myocardial Injury in Athletes: Rajpal S, et al. Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection. JAMA Cardiol. Sep 2020.
- Acute Myocardial Injury is Observed in ~30% of Hospitalized COVID-19 Patients
- Prasitlumkum N, et al. Incidence of Myocardial Injury in COVID-19-Infected Patients: A Systematic Review and Meta-Analysis. Diseases. Oct 2020.
- Smilowitz NR, et al. Myocardial Injury in Adults Hospitalized with COVID-19. Circulation. Nov 2020.
- Giustino G, et al. Characterization of Myocardial Injury in Patients with COVID-19. J Am Coll Cardiol. Oct 2020. (Accompanying Commentary)
- Basso C, et al. Pathological Features of COVID-19-Associated Myocardial Injury: A Multicentre Cardiovascular Pathology Study. Eur Heart J. Sep 2020.
- Lala A, et al. Prevalence and Impact of Myocardial Injury in Patients Hospitalized with COVID-19 Infection. J Am Coll Cardiol. Jun 2020.
- Bois MC, et al. COVID-19-Associated Non-Occlusive Fibrin Microthrombi in the Heart. Circulation. Nov 2020.
- Wei JF, et al. Acute Myocardial Injury is Common in Patients with COVID-19 and Impairs Their Prognosis. Heart. Apr 2020.
- Metkus TS, et al. Myocardial Injury in Severe COVID-19 Compared to Non-COVID Acute Respiratory Distress Syndrome. Circulation. Nov 2020.
- Shi S, et al. Characteristics and Clinical Significance of Myocardial Injury in Patients with Severe Coronavirus Disease 2019. Eur Heart J. May 2020.
- Guo T, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. Mar 2020.
- Clerkin KJ, et al. COVID-19 and Cardiovascular Disease. Circulation. Mar 2020.
- Bangalore S, et al. ST-Segment Elevation in Patients with COVID-19—A Case Series. N Engl J Med. Apr 2020.
- Imazio M, et al. COVID-19 Pandemic and Troponin: Indirect Myocardial Injury, Myocardial Inflammation or Myocarditis? Heart. Jun 2020.
- Halushka MK, et al. Myocarditis is Rare in COVID-19 Autopsies: Cardiovascular Findings Across 277 Postmortem Examinations. Cardiovasc Pathol. Oct 2020.
- Inciardi RM, et al. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. Mar 2020.
- Use of ACEI or ARB is Not Contraindicated in COVID-19
- Cohen JB, et al. Continuation Versus Discontinuation of Renin–Angiotensin System Inhibitors in Patients Admitted to Hospital with COVID-19: A Prospective, Randomised, Open-Label Trial. Lancet Respir Med. Jan 2021.
- Xu J, et al. The Effect of Prior ACEI/ARB Treatment on COVID-19 Susceptibility and Outcome: A Systematic Review and Meta-Analysis. Clin Infect Dis. Oct 2020.
- Mackey K, et al. Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults. Ann Intern Med. May 2020.
- de Abajo FJ, Rodríguez-martín S, Lerma V, et al. Use of Renin-Angiotensin-Aldosterone System Inhibitors and Risk of COVID-19 Requiring Admission to Hospital: A Case-Population Study. Lancet. May 2020.
- Fosbøl EL, et al. Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality. JAMA. Jun 2020.
- Mancia G, et al. Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19. N Engl J Med. May 2020.
- Reynolds HR, et al. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19. N Engl J Med. May 2020.
- de Abajo FJ, et al. Use of Renin-Angiotensin-Aldosterone System Inhibitors and Risk of COVID-19 Requiring Admission to Hospital: A Case-population Study. Lancet. May 2020.
- Zhang P, et al. Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19. Circ Res. Apr 2020;
- Brojakowska A, et al. Clinical Implications of SARS-Cov2 Interaction with Renin Angiotensin System. J Am Coll Cardiol. Apr 2020.
- Reynolds HR, et al. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of COVID-19. N Engl J Med. Jun 2020.
- Bean DM, et al. Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Are Not Associated with Severe COVID-19 Infection in a Multi-Site UK Acute Hospital Trust. Eur J Heart Fail. Jun 2020.
- Ventricular Dysfunction and Ventricle Diastolic Function Has Been Observed in COVID-19 and May Be Associated with Increased Mortality
- Argulian E, et al. Right Ventricular Dilation in Hospitalized Patients with COVID-19 Infection. JACC Cardiovasc Imaging. May 2020.
- Szekely Y, et al. The Spectrum of Cardiac Manifestations in Coronavirus Disease 2019 (COVID-19) – A Systematic Echocardiographic Study. Circulation. May 2020.
- Dweck MR, et al. Global Evaluation of Echocardiography in Patients with COVID-19. Eur Heart J Cardiovasc Imaging. Jun 2020.
- Antecedent Statin Use in Patients Hospitalized with COVID-19 Appears to Be Associated with Lower Inpatient Mortality
- Coagulopathy
Cardiology
Last Updated on 03/18/2021 @ 3:03 PM EDT